271 related articles for article (PubMed ID: 7537849)
1. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.
Gustafson TA; He W; Craparo A; Schaub CD; O'Neill TJ
Mol Cell Biol; 1995 May; 15(5):2500-8. PubMed ID: 7537849
[TBL] [Abstract][Full Text] [Related]
2. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains.
He W; O'Neill TJ; Gustafson TA
J Biol Chem; 1995 Oct; 270(40):23258-62. PubMed ID: 7559478
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
[TBL] [Abstract][Full Text] [Related]
4. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.
Craparo A; O'Neill TJ; Gustafson TA
J Biol Chem; 1995 Jun; 270(26):15639-43. PubMed ID: 7541045
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786.
Sawka-Verhelle D; Tartare-Deckert S; White MF; Van Obberghen E
J Biol Chem; 1996 Mar; 271(11):5980-3. PubMed ID: 8626379
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
Tartare-Deckert S; Sawka-Verhelle D; Murdaca J; Van Obberghen E
J Biol Chem; 1995 Oct; 270(40):23456-60. PubMed ID: 7559507
[TBL] [Abstract][Full Text] [Related]
7. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
8. The role of the NPXY motif in the insulin receptor in tyrosine phosphorylation of insulin receptor substrate-1 and Shc.
Kaburagi Y; Yamamoto-Honda R; Tobe K; Ueki K; Yachi M; Akanuma Y; Stephens RM; Kaplan D; Yazaki Y; Kadowaki T
Endocrinology; 1995 Aug; 136(8):3437-43. PubMed ID: 7543044
[TBL] [Abstract][Full Text] [Related]
9. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a direct interaction between insulin receptor substrate-1 and Shc.
Kasus-Jacobi A; Perdereau D; Tartare-Deckert S; Van Obberghen E; Girard J; Burnol AF
J Biol Chem; 1997 Jul; 272(27):17166-70. PubMed ID: 9202037
[TBL] [Abstract][Full Text] [Related]
11. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
12. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
13. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
Rajala RV; Chan MD
Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
[TBL] [Abstract][Full Text] [Related]
14. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
[TBL] [Abstract][Full Text] [Related]
16. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
17. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.
Wolf G; Trüb T; Ottinger E; Groninga L; Lynch A; White MF; Miyazaki M; Lee J; Shoelson SE
J Biol Chem; 1995 Nov; 270(46):27407-10. PubMed ID: 7499194
[TBL] [Abstract][Full Text] [Related]
18. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
Goalstone ML; Leitner JW; Berhanu P; Sharma PM; Olefsky JM; Draznin B
J Biol Chem; 2001 Apr; 276(16):12805-12. PubMed ID: 11278505
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system.
O'Neill TJ; Craparo A; Gustafson TA
Mol Cell Biol; 1994 Oct; 14(10):6433-42. PubMed ID: 7935368
[TBL] [Abstract][Full Text] [Related]
20. In vitro binding and phosphorylation of insulin receptor substrate 1 by the insulin receptor. Role of interactions mediated by the phosphotyrosine-binding domain and the pleckstrin-homology domain.
Backer JM; Wjasow C; Zhang Y
Eur J Biochem; 1997 Apr; 245(1):91-6. PubMed ID: 9128728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
